Pharmicell Co (XKRX:005690) Short-Term Debt : ₩2,485 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Short-Term Debt?

Pharmicell Co's Short-Term Debt for the quarter that ended in Mar. 2024 was ₩2,485 Mil.

Pharmicell Co's quarterly Short-Term Debt declined from Sep. 2023 (₩4,341 Mil) to Dec. 2023 (₩2,442 Mil) but then increased from Dec. 2023 (₩2,442 Mil) to Mar. 2024 (₩2,485 Mil).

Pharmicell Co's annual Short-Term Debt declined from Dec. 2021 (₩17,048 Mil) to Dec. 2022 (₩16,680 Mil) and declined from Dec. 2022 (₩16,680 Mil) to Dec. 2023 (₩2,442 Mil).

Pharmicell Co Short-Term Debt Historical Data

The historical data trend for Pharmicell Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Short-Term Debt Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

3,000.00

17,048.27

16,680.48

2,441.98

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															16,971.39	15,699.39	4,341.15	2,441.98	2,485.04

Pharmicell Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Pharmicell Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Pharmicell Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines